SEARCH

SEARCH BY CITATION

References

  • Bassat Q, Mulenga M, Tinto H et al. (2009) Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One 4, e7871.
  • Checchi F, Piola P, Fogg C et al. (2006) Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda. Malaria Journal 5, 59.
  • FAO (2008) Food and Agriculture Organization of the United Nations Statistics Division. http://www.fao.org/statistics/en/.
  • Faucher JF, Aubouy A, Adeothy A et al. (2009) Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated Plasmodium falciparum malaria in Benin: a randomized effectiveness non-inferiority trial. Journal of Infectious Diseases 200, 5765.
  • Four Artemisinin-Based Combinations (4ABC) Study Group (2011) A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS Medicine 8, e1001119.
  • Kabanywanyi AM, Lengeler C, Kasim P et al. (2010) Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania. Malaria Journal 9, 48.
  • Kobbe R, Klein P, Adjei S et al. (2008) A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children. Malaria Journal 7, 261.
  • Maude RJ, Pontavornpinyo W, Saralamba S et al. (2009) The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malaria Journal 8, 31.
  • Ministere de la Santé/PNLP(2006) Directives Nationales pour la prise en charge du paludisme au Burkina Faso.
  • Mutabingwa TK, Anthony D, Heller A et al. (2005) Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 365, 14741480.
  • Ngasala BE, Malmberg M, Carlsson AM et al. (2011a) Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study. Malaria Journal 10, 64.
  • Ngasala BE, Malmberg M, Carlsson AM et al. (2011b) Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children < 5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial. Clinical Infectious Diseases 52, 873882.
  • Piola P, Fogg C, Bajunirwe F et al. (2005) Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Lancet 365, 14671473.
  • Plowe CV, Djimdé A, Bouare M, Doumbo O & Wellems TE (1995) Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. American Journal of Tropical Medicine and Hygiene 52, 565568.
  • Premji ZG, Abdulla S, Ogutu B et al. (2008) The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence. Malaria Journal 7, 244.
  • Ranford-Cartwright LC, Taylor J, Umasunthar T et al. (1997) Molecular analysis of recrudescent parasite in a Plasmodium falciparum drug efficacy trial in Gabon. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 719724.
  • Schmidt LE & Dalhoff K (2002) Food-drug interactions. Drugs 62, 14811502.
  • Siribié M, Diarra A, Tiono AB, Soulama I & Sirima SB (2012) Efficacy of artemether-lumefantrine in the treatment of uncomplicated malaria in children living in a rural area of Burkina Faso in 2009. Bulletin de la Societé de Patholologie Exotique 5, 202207.
  • Sirima SB, Tiono AB, Gansané A et al. (2009) The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malaria Journal 8, 48.
  • Tinto H, Zoungrana EB, Coulibaly SO et al. (2002) Chloroquine and sulfadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo Dioulasso, Burkina Faso, during a 3-year period (1998–2000). Tropical Medicine and International Health 7, 925930.
  • White NJ, van Vugt M & Ezzet F (1999) Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. Clinical Pharmacokinetics 37, 105125.
  • WHO (2000) Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 94 (Suppl. 1), 190.
  • WHO (2003) Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. WHO, Geneva.
  • WHO (2007a) Containment of malaria multi-drug resistance on the Cambodia-Thailand border: report of an informal consultation. World Health Organization, WHO press, Geneva. http://www.who.int/malaria/publications/multi_drug_resistance_en.pdf.
  • WHO (2007b) Global malaria control and elimination: report of a meeting on containment of artemisinin tolerance. World Health Organization, WHO press, Geneva. http://www.who.int/malaria/publications/multi_drug_resistance_en.pdf.
  • WHO (2010). Guidelines for the Treatment of Malaria, 2nd edn. World Health Organization, WHO press, Geneva. http://whqlibdoc.who.int/publications/2010/9789241547925eng.pdf.
  • Zongo I, Dorsey G, Rouamba N et al. (2007a) Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clinical Infectious Diseases 45, 14531461.
  • Zongo I, Dorsey G, Rouamba N et al. (2007b) Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Lancet 369, 491498.
  • Zwang J, Olliaro P, Barennes H et al. (2009) Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malaria Journal 8, 203.